Gentera’s loan portfolio grew 16% year-over-year in Q3 2025. That is a strong number by any reasonable standard. It is also materially below the 21.6% posted in Q2 and the 24.5% delivered a year earlier. The deceleration is unmistakable, and after a stock that has re-rated significantly over the past 18 months, the natural question is whether the best of the Gentera story is already priced in.
We think the answer is no, and the deceleration itself is part of the reason.
The growth trajectory in context
To understand what is happening at Gentera, it helps to look at the loan book growth trajectory over the past several quarters. In FY 2024, the consolidated portfolio grew 27%, with Banco Compartamos in Mexico delivering 29% growth and individual lending products surging 48%. That was an exceptional year, fueled by a rapid expansion of the sales force, the rollout of individual credit products alongside the traditional communal lending model, and a recovery in Peru.
Through the first half of 2025, growth remained above 20%, with Q2 reporting a consolidated portfolio of MXN 83.7 billion, up 21.6% year-over-year. Compartamos and ConCredito both maintained annual growth above 20%. Management guided for approximately 15% consolidated portfolio growth for FY 2025, implying a deliberate moderation in the second half.
Q3 2025 confirmed that trajectory: 16% growth, with Compartamos at 19% and overall client growth at 11%. The numbers are decelerating because management is engineering them to decelerate. And that distinction matters enormously.
Why slower growth is not a warning sign
Gentera operates in microfinance. The clients are small-business owners, market vendors, and entrepreneurs at the base of Mexico’s economic pyramid, many of them women. The group lending model, where borrowers collectively guarantee each other’s repayments, has been the backbone of Compartamos since its founding. This model works because it selects for creditworthy borrowers and creates social accountability.
When a microfinance lender grows its portfolio at 27% per year, it is adding clients and disbursing loans faster than its collection infrastructure and credit culture can organically scale. This is not inherently dangerous, but it requires discipline. The risk is not that demand is weakening. The risk would be if management kept pushing 25%+ growth into a consumer base where credit quality has not been tested at that velocity.
Gentera’s Q3 2025 NPL ratio of 3.4% provides the answer. That sits comfortably below the company’s own 3.5-4.0% healthy threshold, and it has been stable for three consecutive quarters. The cost of risk is tracking below the 13% guidance for FY 2025. At a 222% coverage ratio (as of the most recent full-year data), provisions are conservative by any Latin American banking standard.
In other words, the loan book is growing at 16% with stable asset quality. That is a more durable trajectory than 27% growth that might require provision increases down the road.
The NIM expansion that nobody is talking about
The real story of 2025 is not the loan book. It is the net interest margin.
Gentera’s NIM expanded to 40.9% in Q2 2025, well above the 39.8% reported for FY 2024 and above management’s own expectations. The driver is straightforward: as Banxico cuts rates, Gentera’s funding costs decline faster than its lending rates adjust. Microfinance lending rates are structurally sticky because they are determined by product design and credit risk, not by the reference rate. A 25-basis-point cut in the Banxico rate does not translate into a 25bp reduction in the interest rate charged to a communal borrower.
This asymmetry creates a natural NIM tailwind in a rate-cutting cycle. Every Banxico cut compresses the cost of Gentera’s deposit base and wholesale funding while leaving the asset yield largely unchanged. If Banxico delivers the three to four additional cuts that the market expects through the first half of 2026, Gentera’s NIM could sustain levels above 40% for the foreseeable future.
For a financial institution growing its loan book at mid-teens and expanding its NIM simultaneously, the earnings trajectory is more favorable than headline portfolio growth alone would suggest. Net income for Q3 2025 grew faster than the portfolio, and that gap is the NIM effect at work.
Portfolio growth vs. NIM, 2024-2025
Portfolio growth (bars) vs. NIM (line), quarterly
Source: Gentera quarterly filings, 2024-2025.
The insurance business is becoming material
A development that receives almost no English-language coverage is the maturation of Gentera’s insurance platform. As of Q3 2025, insurance products contributed 11% of total income, up from negligible levels just a few years ago. Active insurance policies reached 17.3 million by the end of 2024, growing 43% year-over-year.
This matters for two reasons. First, insurance income is fee-based and capital-light. It does not consume balance sheet capacity, it does not require provisions, and it diversifies revenue away from the credit cycle. Second, it deepens the client relationship. A borrower who also has a life insurance policy through Gentera is stickier than one who only has a loan. The cross-selling engine is working, and it provides a natural buffer against the inevitable cyclical volatility of the credit portfolio.
Net fees grew 31.5% year-over-year in FY 2025 to MXN 6.2 billion, driven primarily by insurance. That growth rate is nearly triple the loan book growth rate, and it is a signal that Gentera’s earnings are becoming structurally less cyclical than they were five years ago.
Income composition: net interest income vs. net fees, FY 2023-2025
Source: Gentera annual filings. MXN billions. Percentage labels show net fees as share of total income.
Peru: the turnaround that still needs to prove itself
Gentera’s Peru operation, Compartamos Financiera, has been the persistent weak spot. The subsidiary barely grew its portfolio in 2024 (1.5% in local currency), struggled with elevated NPLs, and required management attention that could have been deployed elsewhere.
By Q3 2025, there were signs of improvement. Portfolio growth had reinitiated, asset quality was stabilizing, and the Peru operation was approaching profitability targets. But “approaching” is not “achieving,” and Peru remains the segment most likely to surprise negatively. A renewed deterioration in Peruvian consumer credit quality, whether from political instability or macroeconomic softening, would disproportionately affect consolidated cost of risk.
The good news is that Peru represents a manageable share of the consolidated portfolio. The bad news is that management has repeatedly indicated that Peru can be a growth lever, which means expectations are building for a subsidiary that has not yet consistently delivered.
The valuation question
Gentera’s stock has re-rated significantly. The ROE exceeded 23% in recent quarters and is tracking toward the highest levels in a decade. Earnings per share through the first three quarters of 2025 are running well ahead of FY 2024’s MXN 3.80. The market has noticed.
The question for investors evaluating the stock at current levels is whether the re-rating is complete. We see two arguments on each side.
The bull case rests on three pillars: NIM expansion has further room to run as Banxico continues cutting; the insurance business adds a durable, capital-light earnings stream that the market may be undervaluing in its P/B framework; and the dividend payout, currently at 40% of net income, has room to increase as capital adequacy ratios remain well above regulatory minimums. A dividend upgrade would be a powerful signal to the market that management views the current earnings level as sustainable, not cyclical.
The bear case focuses on three risks: the stock has already priced in most of the NIM benefit; opex growth of 25.2% in Q3 2025, driven by hiring and strategic initiatives, could pressure the efficiency ratio if revenue growth decelerates further; and the fintech threat, while currently contained, introduces long-term structural uncertainty. Digital lenders like Nubank Mexico and Clip are expanding into adjacent segments of the Mexican consumer credit market. They lack Gentera’s deposit base and community lending infrastructure, but they have lower marginal acquisition costs and a technology-first approach that could eventually pressure Gentera’s pricing power.
The bottom line
Loan book growth is slowing because management is choosing to slow it, not because demand is fading. The deceleration from 27% to mid-teens is a sign of discipline in a segment where aggressive growth eventually destroys value through credit losses. The more important story is NIM expansion driven by the Banxico easing cycle, a maturing insurance business that diversifies the earnings base, and an ROE trajectory that justifies the re-rating.
The question is not whether Gentera is a good business. It clearly is. The question is whether the current price fully reflects a financial institution delivering 23%+ ROE with expanding margins and a growing non-credit revenue stream. We think it does not, because the English-language investment community still categorizes Gentera as a microfinance lender rather than a diversifying financial services platform, and that framing undervalues the structural earnings improvement underway.
If Banxico cuts three more times before mid-2026 and the insurance business sustains 30%+ fee income growth, the Gentera earnings trajectory over the next 12 months will look better than the decelerating loan book headline suggests. The market may be reading the slowdown as a warning. We read it as maturity.